Table 3 Patient characteristics according to survivors, early death, and late death
From: Reversal of neutrophil-to-lymphocyte count ratio in early versus late death from septic shock
Survivors (n = 76) (1) | Early death (n = 33) (2) | Late death (n = 21) (3) | p Value (2) vs (1 + 3) | p Value (2) vs (3) | |
|---|---|---|---|---|---|
Age, yr | 70.7 (57.9–81.7) | 74.7 (65–81.9) | 77.9 (64.4–85.7) | 0.57 | 0.38 |
Female | 31 (40.8) | 14 (42.4) | 9 (42.9) | 0.9 | 0.97 |
Male | 45 (59.2) | 19 (57.6) | 12 (57.1) | 0.97 | |
Comorbidities | |||||
CAD | 14 (18.4) | 7 (21.2) | 3 (14.3) | 0.64 | 0.51 |
Diabetes | 16 (21.1) | 5 (15.2) | 7 (33.3) | 0.30 | 0.12 |
COPD | 8 (10.5) | 3 (9.1) | 2 (9.5) | 0.84 | 0.96 |
Cancer/immunosuppression | 19 (25) | 8 (24.2) | 6 (28.6) | 0.86 | 0.73 |
Charlson comorbidity index score | 5 (3–6) | 5 (4–6) | 5 (4–7) | 0.15 | 0.97 |
Severity and outcome | |||||
SAPS II | 44 (39.8–54) | 64 (56–76) | 55 (49–61) | <0.0001 | 0.003 |
SOFA score at admission | 7 (5.8–9) | 13 (10–16) | 8 (6–9) | <0.0001 | 0.0004 |
In-ICU LOS | 7 (4–11.2) | 2 (1–2) | 14 (10–22) | <0.0001 | <0.0001 |
Hospital-acquired infection | 12 (15.8) | 3 (9.1) | 14 (66.7) | 0.035 | <0.0001 |
Cell counts at admission | |||||
Neutrophils, 109/L | 9.7 (5.5–16.5) | 6.9 (2.5–16.3) | 10.9 (6.1–13.2) | 0.15 | 0.25 |
Lymphocytes, 109/L | 0.7 (0.5–1.1) | 0.9 (0.6–1.6) | 1.2 (0.9–2) | 0.35 | 0.17 |
NLCR | 12.5 (6.5–21.2) | 5 (3.5–11.6) | 7 (4–12.9) | 0.011 | 0.41 |